Shigaki Takahiro, Hisaka Toru, Fujita Fumihiko, Kusano Hironori, Naito Yoshiki, Midorikawa Ryuta, Ohchi Takafumi, Shiratsuchi Ichitaro, Hidaka Atsuhiro, Tanaka Takaho, Akagi Yoshito
Department of Surgery, Kurume University Hospital, Kurume, Fukuoka 830-0011, Japan.
Department of Pathology, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Mol Clin Oncol. 2019 May;10(5):516-520. doi: 10.3892/mco.2019.1831. Epub 2019 Mar 20.
Mixed carcinoma of the pancreas is defined as the concurrent existence of pancreatic ductal carcinoma, acinar cell carcinoma, and/or islet cell carcinoma within the same neoplasm. We herein report a rare case of mixed ductal-acinar cell carcinoma in a 74-year-old man who was undergoing treatment for hypertension and diabetes at another hospital. After an abrupt worsening of his blood glucose control, the patient was referred to our hospital for further evaluation. Abdominal contrast-enhanced computed tomography and magnetic resonance imaging revealed a tumor with a multilocular cystic lesion in the head of the pancreas. Endoscopic retrograde cholangiopancreatography revealed obstruction of the main pancreatic duct and dilation of the dorsal pancreatic duct; in addition, adenocarcinoma was detected in the pancreatic juice cytology. Based on the abovementioned findings, the patient was diagnosed with carcinoma of the pancreatic head and underwent subtotal stomach-preserving pancreaticoduodenectomy. Based on the histopathological and immunohistochemical findings, the patient was diagnosed with mixed ductal-acinar cell carcinoma. The patient was prescribed TS-1 as postoperative adjuvant chemotherapy upon discharge. However, treatment was discontinued 2 months later due to marked general malaise, and the patient succumbed to tumor recurrence in the residual pancreas 12 months after the surgery.
胰腺混合癌被定义为在同一肿瘤内同时存在胰腺导管癌、腺泡细胞癌和/或胰岛细胞癌。我们在此报告一例罕见的胰腺导管-腺泡细胞混合癌病例,患者为一名74岁男性,正在另一家医院接受高血压和糖尿病治疗。在其血糖控制突然恶化后,该患者被转诊至我院进行进一步评估。腹部增强计算机断层扫描和磁共振成像显示胰腺头部有一个多房囊性病变的肿瘤。内镜逆行胰胆管造影显示主胰管梗阻和背侧胰管扩张;此外,在胰液细胞学检查中检测到腺癌。基于上述发现,该患者被诊断为胰头癌,并接受了保留部分胃的胰十二指肠切除术。根据组织病理学和免疫组化结果,该患者被诊断为导管-腺泡细胞混合癌。患者出院时被给予替吉奥作为术后辅助化疗。然而,2个月后由于明显的全身不适而停止治疗,患者在手术后12个月死于残留胰腺的肿瘤复发。